Brookstone Capital Management Boosts Stake in Intuitive Surgical, Inc. $ISRG

Brookstone Capital Management increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 48.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,707 shares of the medical equipment provider’s stock after purchasing an additional 12,014 shares during the quarter. Brookstone Capital Management’s holdings in Intuitive Surgical were worth $16,416,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Norges Bank purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $2,569,260,000. Vanguard Group Inc. raised its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after acquiring an additional 670,302 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Jennison Associates LLC lifted its holdings in Intuitive Surgical by 20.4% during the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. boosted its position in shares of Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.1%

Shares of Intuitive Surgical stock opened at $578.10 on Thursday. The firm has a market cap of $207.24 billion, a price-to-earnings ratio of 76.47, a PEG ratio of 5.28 and a beta of 1.68. The business has a 50-day moving average price of $550.03 and a 200-day moving average price of $506.41. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the company earned $1.84 earnings per share. The firm’s revenue was up 22.9% on a year-over-year basis. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity

In related news, SVP Mark Brosius sold 4,500 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the transaction, the senior vice president directly owned 907 shares of the company’s stock, valued at approximately $496,455.52. This trade represents a 83.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of the company’s stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently commented on ISRG shares. Evercore ISI raised their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. Wells Fargo & Company raised their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Leerink Partners boosted their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Daiwa Capital Markets increased their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research report on Friday, October 24th. Finally, Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $611.08.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.